$2.47

0.01 (0.40%)

Want access to our research and new buy ideas?

Take a free 15 day trial - no credit card required.

Start your free trial now

HSO General Information

Healthscope Limited
HSO
http://www.healthscope.com.au
Health Care Facilities
4,300
1,741

HSO Current Share Price+

Current Price $2.470
Open $2.480
High $2.480
Low $2.465
Last Close $2.480
Volume 5690766
Price Movement $0.01 ( 0.40% )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

HSO Research

HSO Recommendation

Current recommendation UNLOCK
12 month range UNLOCK
Maximum portfolio weighting UNLOCK
Business risk UNLOCK
Share price risk UNLOCK

HSO Company Overview

Business Description

Healthscope Limited (HSO) is a private healthcare provider with 43 private hospitals in Australia and 24 pathology laboratories in New Zealand. The operations of the Group include Hospitals Australia and New Zealand Pathology.

HSO Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2020 F 185.23 10.65 9.20% 23.19 7.00 2.83% 0.0%
2019 F 169.61 9.75 12.50% 25.33 7.00 2.83% 0.0%
2018 A 151.20 8.67 -16.20% 23.30 6.70 3.32% 0.0%

HSO Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2018 A 2019 F 2020 F 2018 A 2019 F 2020 F 2018 A 2019 F 2020 F
Estia Health (EHE) $644M -0.0571 -0.0221 0.0429 14.3939 14.7199 14.1143 6.40% 6.80% 7.09%
Healthscope (HSO) $4,318M -0.3327 0.3614 0.0899 36.5782 26.8689 24.6521 2.70% 2.81% 2.90%
Japara Healthcare (JHC) $367M -0.3578 -0.0975 0.1497 19.1504 21.2191 18.4564 5.64% 4.73% 5.38%
Regis Healthcare (REG) $1,016M -0.0739 -0.0940 0.1341 17.8553 19.7085 17.3779 5.30% 5.08% 5.76%
Ramsay Health Care (RHC) $12,036M 0.0751 0.1256 0.0797 23.5071 20.8836 19.3421 2.42% 2.45% 2.64%

HSO Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 1.13 29.50 1.83 1.35
Market 0.91 16.70 1.50 1.66
Sector 0.80 17.50 1.82 2.95

HSO Directors

Name Position Start Date
Mr Gordon Ballantyne Chief Executive Officer, Managing Director 16 May 2017
Ms Paula Jane Dwyer Non-Executive Chairman, Non-Executive Director 28 Jun 2014
Mr Rupert H Myer Non-Executive Director 28 Jun 2014
Dr Zygmunt (Ziggy) Edward Switkowski Non-Executive Director 4 Apr 2016
Mr Antoni Michael Cipa Non-Executive Director 28 Jun 2014
Dr Michael Philip Stanford Non-Executive Director 26 Mar 2018
Ms Jane Frances McAloon Non-Executive Director 1 Mar 2016
Mr Paul Dominic O'Sullivan Non-Executive Director 1 Jan 2016

HSO Management

Name Position
Michael Sammells Chief Financial Officer
Michael Coglin Chief Medical Officer
Ingrid Player General Counsel,Company Secretary
Anoop Singh General Manager International Pathology
Mark Briscoe General Manager Operations
Katherine Paroz Group Executive Human Resources
Ingrid Player Group Executive Legal, Governance & Sustainability
Richard Herman Head of Assurance
Stephen Gameren Hospitals State Manager NSW & ACT
Arthur Yannakou Hospitals State Manager QLD, NT & WA
Alan Lane Hospitals State Manager SA & ACHA Chief Executive Officer
Bronte Kumm Hospitals State Manager VIC & TAS
Cathy Jones National Manager Quality & Compliance

HSO Substantial Shareholders

Holding Name
252,643,305 (14.52%) BGH Capital Pty Ltd
176,111,600 (10.10%) NorthWest Healthcare Properties Real Estate Investment Trust
163,142,252 (9.38%) Ellerston Capital Limited and its associates
87,122,354 (5.01%) The Vanguard Group,Inc

HSO Calendar of Events

Date Event
13 February 2020 Report (Interim)
20 August 2019 Report (Annual)
20 August 2019 Report (Prelim)
26 March 2019 Div Pay Date
05 March 2019 Books Close
04 March 2019 Div Ex Date

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.